These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32250320)

  • 1. Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study.
    Bakshi R; Macklin EA; Hung AY; Hayes MT; Hyman BT; Wills AM; Gomperts SN; Growdon JH; Ascherio A; Scherzer CR; Schwarzschild MA
    J Parkinsons Dis; 2020; 10(2):505-510. PubMed ID: 32250320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher urate in LRRK2 mutation carriers resistant to Parkinson disease.
    Bakshi R; Macklin EA; Logan R; Zorlu MM; Xia N; Crotty GF; Zhang E; Chen X; Ascherio A; Schwarzschild MA
    Ann Neurol; 2019 Apr; 85(4):593-599. PubMed ID: 30761591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma urate and risk of Parkinson's disease.
    Weisskopf MG; O'Reilly E; Chen H; Schwarzschild MA; Ascherio A
    Am J Epidemiol; 2007 Sep; 166(5):561-7. PubMed ID: 17584757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma urate and Parkinson's disease in women.
    O'Reilly EJ; Gao X; Weisskopf MG; Chen H; Schwarzschild MA; Spiegelman D; Ascherio A
    Am J Epidemiol; 2010 Sep; 172(6):666-70. PubMed ID: 20682521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
    Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Pachi I; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2020; 10(2):481-487. PubMed ID: 32176655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Serum Urate Change as Parkinson's Disease Progresses?
    Hasimoglu YG; Chen X; Bakshi R; Schwarzschild MA; Macklin EA
    J Parkinsons Dis; 2020; 10(4):1571-1576. PubMed ID: 32773396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
    Schwarzschild MA; Macklin EA; Bakshi R; Battacharyya S; Logan R; Espay AJ; Hung AY; Bwala G; Goetz CG; Russell DS; Goudreau JL; Parashos SA; Saint-Hilaire MH; Rudolph A; Hare JM; Curhan GC; Ascherio A;
    Neurology; 2019 Oct; 93(14):e1328-e1338. PubMed ID: 31484712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of plasma urate and risk of Parkinson disease in men and women.
    Gao X; O'Reilly ÉJ; Schwarzschild MA; Ascherio A
    Neurology; 2016 Feb; 86(6):520-6. PubMed ID: 26764029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet, urate, and Parkinson's disease risk in men.
    Gao X; Chen H; Choi HK; Curhan G; Schwarzschild MA; Ascherio A
    Am J Epidemiol; 2008 Apr; 167(7):831-8. PubMed ID: 18326873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants related to urate and risk of Parkinson's disease.
    Hughes KC; Gao X; O'Reilly EJ; Kim IY; Wang M; Weisskopf MG; Schwarzschild MA; Ascherio A
    Parkinsonism Relat Disord; 2018 Aug; 53():4-9. PubMed ID: 29789205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urate as a predictor of the rate of clinical decline in Parkinson disease.
    Ascherio A; LeWitt PA; Xu K; Eberly S; Watts A; Matson WR; Marras C; Kieburtz K; Rudolph A; Bogdanov MB; Schwid SR; Tennis M; Tanner CM; Beal MF; Lang AE; Oakes D; Fahn S; Shoulson I; Schwarzschild MA;
    Arch Neurol; 2009 Dec; 66(12):1460-8. PubMed ID: 19822770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma urate and risk of Parkinson's disease: A mendelian randomization study.
    Kobylecki CJ; Nordestgaard BG; Afzal S
    Ann Neurol; 2018 Aug; 84(2):178-190. PubMed ID: 30014508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urate and the risk of Parkinson's disease in men and women.
    Cortese M; Riise T; Engeland A; Ascherio A; Bjørnevik K
    Parkinsonism Relat Disord; 2018 Jul; 52():76-82. PubMed ID: 29615298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.
    Picillo M; Santangelo G; Moccia M; Erro R; Amboni M; Prestipino E; Longo K; Vitale C; Spina E; Orefice G; Barone P; Pellecchia MT
    J Neural Transm (Vienna); 2016 Apr; 123(4):371-7. PubMed ID: 26739446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urate as a marker of development and progression in Parkinson's disease.
    Constantinescu R; Zetterberg H
    Drugs Today (Barc); 2011 May; 47(5):369-80. PubMed ID: 22013567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers for Parkinson's disease by metabolomic technologies.
    Hatano T; Saiki S; Okuzumi A; Mohney RP; Hattori N
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):295-301. PubMed ID: 25795009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.
    Cipriani S; Chen X; Schwarzschild MA
    Biomark Med; 2010 Oct; 4(5):701-12. PubMed ID: 20945982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.